Clinical Trial Update: Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two dosing regimens of T1225 Eye Drops 1.5% with oral Azithromycin for Trachoma has completed, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trachoma

Drugs mentioned

• Azithromycin (azithromycin)
• T1225 Eye Drops 1.5%

Snippet

Sponsor: Laboratoires Thea | Conditions: Trachoma | Phase 3 | Status: COMPLETED